Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome

American Journal of Neuroradiology

Volumn 19, Issue 3, 1998, Pages 415-417

  Ito, Yasuhirou ^a   Arahata, Yutaka ^a   Goto, Yoji ^a   Hirayama, Masaaki ^a   Nagamutsu, Masaaki ^a   Yasuda, Takeshi ^a   Yanagi, Tsutomu ^b   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; GLYCEROL; IFOSFAMIDE; NICARDIPINE; PHENYTOIN; PROPRANOLOL;

AGED; ARM AMPUTATION; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONVULSION; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; LEUKOENCEPHALOPATHY; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; UNCONSCIOUSNESS; VISUAL IMPAIRMENT;

AGED; ANTINEOPLASTIC AGENTS; BRAIN DISEASES; CISPLATIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0032231776     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gorman DJ, Kefford R, Stuart-Harris R. Focal encephalopathy after cisplatin therapy. Med J Aust 1989;150:399-401
2. Lindeman G, Kefford R, Stuart-Harris R. Cisplatin neurotoxicity. N Engl J Med 1990;323:64-65
3. Kattah JC, Potolicchio SJJ, Kotz HL, Kolsky MP, Thomas D. Cortical blindness and occipital lobe seizures induced by cis-platinum. Neuroophthalmology 1987;7:99-104
4. Nomura K, Ohno R, Hamaguchi K, et al. Clinicopathological report of cisplatin encephalopathy. Clin Neurol 1995;35:64-69
5. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500
6. Vaughn DJ, Jarvik JG, Hackney D, Peter S, Stadtmauer EA. High-dose cytarabine neurotoxicity: MR Finding during the acute phase. AJNR Am J Neuroradiol 1993;14:1014-1016
7. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-659
8. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR finding in 16 cases. AJR Am J Roentgenol 1995;165:627-631
9. Mark AL. Cyclosporine, sympathetic activity, and hypertension. N Engl J Med 1990;323:748-750
10. Sloane JP, Lwin KY, Gore ME, Powles RL, Smith JF. Disturbance of blood brain barrier after bone-marrow transplantation. Lancet 1985;2:280-281
11. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest 1986;55: 455-462
12. Sadeh M. Action of magnesium sulfate in the treatment of pre-eclampsia-eclampsia. Stroke 1989;20:1273-1275
13. Thompson CB, June CH, Sullivian KM, Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984;2:1116-1120